ID   NALM-23
AC   CVCL_5663
SY   NALM23
DR   Wikidata; Q54907404
RX   PubMed=1817649;
RX   PubMed=9680106;
RX   PubMed=10071072;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (PubMed=10071072).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C114819; Adult B acute lymphoblastic leukemia with t(9;22)(q34.1;q11.2) BCR-ABL1
DI   ORDO; Orphanet_585909; B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L054 ! B250
OI   CVCL_1836 ! NALM-20
OI   CVCL_1837 ! NALM-21
OI   CVCL_5662 ! NALM-22
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
RX   PubMed=1817649;
RA   Matsuo Y., Ariyasu T., Ohmoto E., Kimura I., Minowada J.;
RT   "Bi-phenotypic t(9;22)-positive leukemia cell lines from a patient
RT   with acute leukemia: NALM-20, established at the onset; and NALM-21,
RT   NALM-22 and NALM-23, established after relapse.";
RL   Hum. Cell 4:335-338(1991).
//
RX   PubMed=9680106; DOI=10.1016/S0145-2126(98)00050-2;
RA   Matsuo Y., Drexler H.G.;
RT   "Establishment and characterization of human B cell precursor-leukemia
RT   cell lines.";
RL   Leuk. Res. 22:567-579(1998).
//
RX   PubMed=10071072; DOI=10.1016/S0145-2126(98)00171-4;
RA   Drexler H.G., MacLeod R.A.F., Uphoff C.C.;
RT   "Leukemia cell lines: in vitro models for the study of Philadelphia
RT   chromosome-positive leukemia.";
RL   Leuk. Res. 23:207-215(1999).
//